0000719135-22-000084.txt : 20220831
0000719135-22-000084.hdr.sgml : 20220831
20220831165138
ACCESSION NUMBER: 0000719135-22-000084
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220829
FILED AS OF DATE: 20220831
DATE AS OF CHANGE: 20220831
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goodwin Charles D. II
CENTRAL INDEX KEY: 0001726988
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31885
FILM NUMBER: 221218510
MAIL ADDRESS:
STREET 1: 5115 ULMERTON ROAD
CITY: CLEARWATER
STATE: FL
ZIP: 33760
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apyx Medical Corp
CENTRAL INDEX KEY: 0000719135
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 112644611
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5115 ULMERTON ROAD
CITY: CLEARWATER
STATE: FL
ZIP: 33760
BUSINESS PHONE: 7273842323
MAIL ADDRESS:
STREET 1: 5115 ULMERTON ROAD
CITY: CLEARWATER
STATE: FL
ZIP: 33760
FORMER COMPANY:
FORMER CONFORMED NAME: BOVIE MEDICAL Corp
DATE OF NAME CHANGE: 20150319
FORMER COMPANY:
FORMER CONFORMED NAME: BOVIE MEDICAL CORP
DATE OF NAME CHANGE: 19990216
FORMER COMPANY:
FORMER CONFORMED NAME: AN CON GENETICS INC
DATE OF NAME CHANGE: 19920703
4
1
wf-form4_166197908352652.xml
FORM 4
X0306
4
2022-08-29
0
0000719135
Apyx Medical Corp
APYX
0001726988
Goodwin Charles D. II
5115 ULMERTON RD
CLEARWATER
FL
33760-4004
1
1
0
0
Chief Executive Officer
Common Stock
2022-08-29
4
P
0
2000
5.93
A
30250
D
Common Stock
2022-08-29
4
P
0
9750
5.97
A
40000
D
This transaction was executed in multiple trades at prices ranging from $5.92 to $5.93. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
This transaction was executed in multiple trades at prices ranging from $5.90 to $5.99. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
s/ Charles D. Goodwin, II
2022-08-31